Asensus Surgical Inc has a consensus price target of $0.17, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 16, 2024, April 4, 2024, and March 22, 2024. With an average price target of $0.9 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 239.62% upside for Asensus Surgical Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/16/2024 | Buy Now | 32.08% | HC Wainwright & Co. | Swayampakula Ramakanth | → $0.35 | Reiterates | Neutral → Neutral | Get Alert |
04/04/2024 | Buy Now | 32.08% | HC Wainwright & Co. | Swayampakula Ramakanth | $2 → $0.35 | Downgrade | Buy → Neutral | Get Alert |
03/22/2024 | Buy Now | 654.72% | HC Wainwright & Co. | Swayampakula Ramakanth | $2 → $2 | Maintains | Buy | Get Alert |
11/16/2023 | Buy Now | — | Cantor Fitzgerald | Ross Osborn | — | Downgrade | Overweight → Neutral | Get Alert |
11/15/2023 | Buy Now | 654.72% | HC Wainwright & Co. | Swayampakula Ramakanth | → $2 | Reiterates | Buy → Buy | Get Alert |
08/22/2023 | Buy Now | 277.36% | Cantor Fitzgerald | Ross Osborn | → $1 | Reiterates | Overweight → Overweight | Get Alert |
08/11/2023 | Buy Now | 654.72% | HC Wainwright & Co. | Swayampakula Ramakanth | → $2 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 654.72% | HC Wainwright & Co. | Swayampakula Ramakanth | → $2 | Reiterates | Buy → Buy | Get Alert |
03/06/2023 | Buy Now | 654.72% | HC Wainwright & Co. | Swayampakula Ramakanth | $3 → $2 | Maintains | Buy | Get Alert |
02/22/2023 | Buy Now | 1032.08% | HC Wainwright & Co. | Swayampakula Ramakanth | → $3 | Reiterates | → Buy | Get Alert |
01/10/2023 | Buy Now | 1032.08% | HC Wainwright & Co. | Swayampakula Ramakanth | → $3 | Reiterates | → Buy | Get Alert |
09/08/2022 | Buy Now | 466.04% | Cantor Fitzgerald | Ross Osborn | → $1.5 | Initiates | → Overweight | Get Alert |
08/10/2022 | Buy Now | 1032.08% | HC Wainwright & Co. | Swayampakula Ramakanth | $4 → $3 | Maintains | Buy | Get Alert |
05/26/2021 | Buy Now | 1409.43% | HC Wainwright & Co. | Swayampakula Ramakanth | — | Initiates | → Buy | Get Alert |
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by HC Wainwright & Co. on May 16, 2024. The analyst firm set a price target for $0.35 expecting ASXC to fall to within 12 months (a possible NaN% downside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by HC Wainwright & Co., and Asensus Surgical reiterated their neutral rating.
There is no last upgrade for Asensus Surgical.
The last downgrade for Asensus Surgical Inc happened on April 4, 2024 when HC Wainwright & Co. changed their price target from $2 to $0.35 for Asensus Surgical Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a reiterated with a price target of $0.00 to $0.35. The current price Asensus Surgical (ASXC) is trading at is $undefined, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.